Capital Impact Advisors LLC increased its holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) by 37.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,612 shares of the company’s stock after purchasing an additional 6,184 shares during the […]
SVB Securities started coverage on shares of Relay Therapeutics (NASDAQ:RLAY – Free Report) in a research note published on Tuesday, FlyOnTheWall reports. The firm issued an outperform rating on the stock. A number of other research firms have also weighed in on RLAY. Stifel Nicolaus dropped their price objective on shares of Relay Therapeutics from […]
Relay Therapeutics (NASDAQ:RLAY – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.81) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.78) by ($0.03), Briefing.com reports. Relay Therapeutics had a negative return on equity of 35.73% and a negative net margin of 27,163.46%. The company had revenue […]
Investment analysts at SVB Securities began coverage on shares of Relay Therapeutics (NASDAQ:RLAY – Get Free Report) in a research note issued on Tuesday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the stock. Other equities analysts have also recently issued research reports about the stock. Raymond James upgraded shares of Relay Therapeutics from […]